Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    February 2019
  1. KWEE SA, Tiirikainen M, Sato MM, Acoba JD, et al
    Transcriptomics associates molecular features with 18F-fluorocholine PET/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-3837.
    PubMed     Text format     Abstract available


  2. HAN J, Meng J, Wang X, Yin S, et al
    YY1 complex promotes Quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-2238.
    PubMed     Text format     Abstract available


  3. XU F, Li CH, Wong CH, Chen GG, et al
    Genome-wide screening and functional analysis identifies tumor suppressor long non-coding RNAs epigenetically silenced in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 4. pii: 0008-5472.CAN-18-1659.
    PubMed     Text format     Abstract available


    December 2018
  4. CHEN SL, Zhang CZ, Liu LL, Lu SX, et al
    A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma.
    Cancer Res. 2018 Dec 24. pii: 0008-5472.CAN-18-2357.
    PubMed     Text format     Abstract available


  5. DONG Q, Du Y, Li H, Liu C, et al
    EGFR and c-MET cooperate to enhance resistance to PARP inhibitors in hepatocellular carcinoma.
    Cancer Res. 2018 Dec 20. pii: 0008-5472.CAN-18-1273.
    PubMed     Text format     Abstract available


  6. WOHLFEIL SA, Hafele V, Dietsch B, Schledzewski K, et al
    Hepatic endothelial Notch activation protects against liver metastasis by regulating endothelial-tumor cell adhesion independent of angiocrine signaling.
    Cancer Res. 2018 Dec 10. pii: 0008-5472.CAN-18-1752.
    PubMed     Text format     Abstract available


  7. GU Y, Wei X, Sun Y, Gao H, et al
    miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features.
    Cancer Res. 2018 Dec 7. pii: 0008-5472.CAN-18-1675.
    PubMed     Text format     Abstract available


    November 2018
  8. PENG L, Jiang B, Yuan X, Qiu Y, et al
    Super-enhancer-associated long non-coding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma.
    Cancer Res. 2018 Nov 27. pii: 0008-5472.CAN-18-0367.
    PubMed     Text format     Abstract available


    October 2018

  9. Correction: Telomerase-dependent Virotherapy Overcomes Resistance of Hepatocellular Carcinomas against Chemotherapy and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand by Elimination of Mcl-1.
    Cancer Res. 2018;78:6026.
    PubMed     Text format    


    September 2018
  10. ROBERTSON CL, Mendoza RG, Jariwala N, Dozmorov M, et al
    Astrocyte elevated gene-1 (AEG-1) regulates macrophage activation in hepatocellular carcinogenesis.
    Cancer Res. 2018 Sep 4. pii: 0008-5472.CAN-18-0659.
    PubMed     Text format     Abstract available


    August 2018
  11. GU L, Zhu Y, Lin X, Li Y, et al
    Amplification of glyceronephosphate O-acyltransferase and recruitment of USP30 stabilize DRP1 to promote hepatocarcinogenesis.
    Cancer Res. 2018 Aug 24. pii: 0008-5472.CAN-18-0340.
    PubMed     Text format     Abstract available


    July 2018
  12. YAO Y, Sun S, Wang J, Fei F, et al
    Canonical Wnt signaling remodels lipid metabolism in zebrafish hepatocytes following Ras oncogenic insult.
    Cancer Res. 2018 Jul 31. pii: 0008-5472.CAN-17-3964.
    PubMed     Text format     Abstract available


  13. MAKINO Y, Hikita H, Kodama T, Shigekawa M, et al
    CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-3844.
    PubMed     Text format     Abstract available


  14. LI Y, Lin S, Li L, Tang Z, et al
    PDSS2 deficiency induces hepatocarcinogenesis by decreasing mitochondrial respiration and reprogramming glucose metabolism.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-2172.
    PubMed     Text format     Abstract available


    June 2018
  15. QI LN, Xiang BD, Wu FX, Ye JZ, et al
    Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma.
    Cancer Res. 2018 Jun 18. pii: 0008-5472.CAN-17-2459.
    PubMed     Text format     Abstract available



  16. Retraction: Identification of Brain-Derived Neurotrophic Factor as a Novel Functional Protein in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3400.
    PubMed     Text format    



  17. Retraction: The Potential Role of Hypoxia Inducible Factor 1alpha in Tumor Progression after Hypoxia and Chemotherapy in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3399.
    PubMed     Text format    


  18. HILL MA, Alexander WB, Guo B, Kato Y, et al
    Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.
    Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-17-1123.
    PubMed     Text format     Abstract available


    May 2018
  19. MENG J, Chen S, Han J, Qian B, et al
    Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma.
    Cancer Res. 2018 May 29. pii: 0008-5472.CAN-17-3009.
    PubMed     Text format     Abstract available


  20. WEN LZ, Ding K, Wang ZR, Ding CH, et al
    SHP-1 acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Cancer Res. 2018 May 18. pii: 0008-5472.CAN-17-3896.
    PubMed     Text format     Abstract available


    March 2018
  21. XU J, Yang Y, Xie R, Liu J, et al
    The NCX1/TRPC6 complex mediates TGFbeta-driven migration and invasion of human hepatocellular carcinoma cells.
    Cancer Res. 2018 Mar 2. pii: 0008-5472.CAN-17-2061.
    PubMed     Text format     Abstract available


  22. SAKAI E, Nakayama M, Oshima H, Kouyama Y, et al
    Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
    Cancer Res. 2018;78:1334-1346.
    PubMed     Text format     Abstract available


  23. VERZELLA D, Bennett J, Fischietti M, Thotakura AK, et al
    GADD45beta Loss Ablates Innate Immunosuppression in Cancer.
    Cancer Res. 2018;78:1275-1292.
    PubMed     Text format     Abstract available


    February 2018
  24. CAI Z, Qian ZY, Jiang H, Ma N, et al
    hPCL3s promotes hepatocellular carcinoma metastasis by activating beta-catenin signaling.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-0028.
    PubMed     Text format     Abstract available


  25. CHENG BY, Lau EY, Leung HW, Leung CO, et al
    IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-2445.
    PubMed     Text format     Abstract available


  26. LIU C, Liu L, Chen X, Cheng J, et al
    LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
    Cancer Res. 2018;78:938-949.
    PubMed     Text format     Abstract available


  27. ZHANG YL, Li Q, Yang XM, Fang F, et al
    SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2867.
    PubMed     Text format     Abstract available


  28. KOHLI S, Bhardwaj A, Kumari R, Das S, et al
    SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
    Cancer Res. 2018;78:645-658.
    PubMed     Text format     Abstract available


    January 2018
  29. RHEE H, Kim HY, Choi JH, Woo HG, et al
    Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis.
    Cancer Res. 2018 Jan 23. pii: 0008-5472.CAN-17-0988.
    PubMed     Text format     Abstract available


  30. SHEN J, Li P, Shao X, Yang Y, et al
    The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
    Cancer Res. 2018;78:359-371.
    PubMed     Text format     Abstract available


    December 2017
  31. JOSHI JJ, Coffey H, Corcoran E, Tsai J, et al
    H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
    Cancer Res. 2017;77:6999-7013.
    PubMed     Text format     Abstract available


    November 2017
  32. YAN Q, Jiang L, Liu M, Yu D, et al
    ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Cancer Res. 2017;77:5831-5845.
    PubMed     Text format     Abstract available


  33. D'COSTA Z, Jones K, Azad A, van Stiphout R, et al
    Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
    Cancer Res. 2017;77:5952-5962.
    PubMed     Text format     Abstract available


    October 2017
  34. ZHANG CZ, Chen SL, Wang CH, He YF, et al
    CBX8 exhibits oncogenic activity via AKT/beta-Catenin activation in hepatocellular carcinoma.
    Cancer Res. 2017 Oct 24. pii: canres.0700.2017.
    PubMed     Text format     Abstract available


  35. TSCHIDA BR, Temiz NA, Kuka TP, Lee LA, et al
    Sleeping Beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumor.
    Cancer Res. 2017 Oct 9. pii: canres.2281.2017.
    PubMed     Text format     Abstract available


    September 2017
  36. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Text format     Abstract available


  37. TENG Y, Zhao H, Gao L, Zhang W, et al
    FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3beta-Nrf2 signaling.
    Cancer Res. 2017 Sep 26. pii: canres.2039.2017.
    PubMed     Text format     Abstract available


  38. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Text format     Abstract available


    August 2017
  39. MENDEZ-LUCAS A, Li X, Hu J, Che L, et al
    Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
    Cancer Res. 2017;77:4355-4364.
    PubMed     Text format     Abstract available


  40. YE J, Li TS, Xu G, Zhao YM, et al
    JCAD Promotes Progression of Non-alcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Cancer Res. 2017 Aug 3. pii: canres.0229.2017.
    PubMed     Text format     Abstract available


  41. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression.
    Cancer Res. 2017;77:4065-4077.
    PubMed     Text format     Abstract available


    July 2017
  42. TILL J, Yoon C, Kim BJ, Roby KC, et al
    Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-cadherin expression.
    Cancer Res. 2017 Jul 31. pii: canres.0061.2017.
    PubMed     Text format     Abstract available


  43. NG KY, Chan LH, Chai S, Tong M, et al
    TP53INP1 down-regulation activates a p73-dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinoma.
    Cancer Res. 2017 Jul 3. pii: canres.3456.2016.
    PubMed     Text format     Abstract available


  44. BARBAZAN J, Alonso-Alconada L, Elkhatib N, Geraldo S, et al
    Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.
    Cancer Res. 2017;77:3431-3441.
    PubMed     Text format     Abstract available


    June 2017
  45. NGO HKC, Kim DH, Cha YN, Na HK, et al
    Nrf2 mutagenic activation drives hepatocarcinogenesis.
    Cancer Res. 2017 Jun 27. pii: canres.3538.2016.
    PubMed     Text format     Abstract available


  46. AKIEL M, Guo C, Li X, Rajasekaran D, et al
    IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Cancer Res. 2017 Jun 15. pii: canres.2885.2016.
    PubMed     Text format     Abstract available


    April 2017
  47. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available


  48. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Text format     Abstract available


  49. YUE F, Li W, Zou J, Jiang X, et al
    Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy.
    Cancer Res. 2017 Apr 6. pii: canres.3462.2016.
    PubMed     Text format     Abstract available


    March 2017
  50. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: